Think Brain Tumor
Minimally invasive, more effective treatments
When it comes to restoring quality of life, experience matters. Our surgeons have helped lead the way world-wide in advancing safe and effective keyhole and endoscopic brain tumor removal. ”Minimally invasive” is here today, every day at PNI. Ask our patients.
Clinical Trials & Novel Approaches
Our neuro-oncologists are at the forefront of applying brain tumor genomics to developing personalized treatments, including the evaluation of clinical trial eligibility. We provide targeted therapies and advanced treatment options patients may not have elsewhere.
Conditions We Treat:
There’s Always Time For a Second Opinion
If you or someone you care for have been recently diagnosed with a brain or skull base tumor (benign or malignant) there’s time for you to get another viewpoint. We’ll provide a rapid review of your medical records and imaging and give you our unique perspective on the optimal treatment pathway.
Get a Second Opinion
If you live in the United States outside Greater Los Angeles or are living abroad, our physicians can promptly review your imaging studies and other tests, and provide a recommendation on treatment options.Get a Second Opinion
Pacific Brain Tumor Center News, Healthy Living and Education
Turning Pain into Progress
Meet Sheena Reddy: A woman honors her mother’s fight against glioblastoma cancer while helping others.
New Hope on Vanquishing a Relentless Killer: Glioblastoma | Dr. Santosh Kesari
Listen to our conversation with Dr. Kesari to find out what GBM treatments make him believe that big breakthroughs are on the horizon for treating this tricky, and tragic, disease.
Becoming Bionic and the Rise of Digital Health Solutions
Technology apps give you power in cancer care In a terrible accident, astronaut Steve Austin was severely injured and rushed to a top-secret high-tech facility. In a government-sanctioned surgery, scientists and doctors worked around the clock using experimental technology to install a bionic arm, eye,…
Developing new Temozolomide analogs to improve brain tumor patient survival
SIGNIFICANCE Glioblastoma (GBM) is the most common and lethal primary malignant brain tumor in adults. Despite the advances in understanding the molecular mechanism underlying GBM tumorigenesis, most of the current targeted therapies are still ineffective and temozolomide (TMZ) has remained the cornerstone of GBM treatment. Treatment…